Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Global Antimicrobial Resistance|December 13, 2022
In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020Naoki Kohira, Meredith A Hackel, Merime Oota, et al.Microbial Drug Resistance (Larchmont, N.Y.)|May 30, 2023
In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014-2019Mark G Wise, James A Karlowsky, Meredith A Hackel, et al.Nihon Hoshasen Gijutsu Gakkai Zasshi|April 22, 2017
Effects of Valsalva Maneuver by Different Breath-holding Techniques to Detect Pulmonary Thromboembolism in a Contrast-enhanced Computed Tomography ExaminationChiaki Suzuki, Kenji Fujisaki, Yuusuke Atsumi, et al.Journal of Medicinal Chemistry|May 8, 2020
Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant BacteriaKouhei Matsui, Yukiko Kan, Junko Kikuchi, et al.Antimicrobial Agents and Chemotherapy|July 3, 2019
In Vivo Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection ModelsRio Nakamura, Tsukasa Ito-Horiyama, Miki Takemura, et al.Journal of Clinical Microbiology|August 20, 2025
The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution methodBoudewijn L M DeJonge, Christine Slover, Sean T Nguyen, et al.Jac-Antimicrobial Resistance|May 9, 2022
Assessment of sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Acinetobacter baumannii using in vitro chemostat and in vivo murine infection modelsChristian M Gill, Kamilia Abdelraouf, Merime Oota, et al.The Journal of Antimicrobial Chemotherapy|July 2, 2021
Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection modelsChristian M Gill, Kamilia Abdelraouf, Merime Oota, et al.Microbiology Spectrum|November 15, 2023
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysisChristopher Longshaw, Anne Santerre Henriksen, Dana Dressel, et al.Microbiology Spectrum|October 13, 2025
Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance programJohn H Kimbrough, Maura H Karr, Sean T Nguyen, et al.Pageof 3